Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction
- 15 June 1991
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 62 (6) , 673-684
- https://doi.org/10.1016/0049-3848(91)90371-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- 4 Bernard-Soulier syndromeBailliere's Clinical Haematology, 1989
- Thrombin Interactions with Platelet Membrane ProteinsaAnnals of the New York Academy of Sciences, 1986
- Identification of the thrombin receptor on human platelets by chemical crosslinking.Journal of Clinical Investigation, 1986
- Partial characterization of a binding site for von Willebrand factor on glycocalicinBlood, 1986
- Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membraneEuropean Journal of Biochemistry, 1985
- Additional glycoprotein defects in Bernard-Soulier's syndrome: confirmation of genetic basis by parental analysisBlood, 1983
- Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factorBlood, 1983
- Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTIONBritish Journal of Haematology, 1981
- Reduced thrombin binding and aggregation in Bernard-Soulier platelets.Journal of Clinical Investigation, 1978
- Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetinThrombosis Research, 1976